Headquartered in New York, NY Fiscal year ends December NYSE: WRBY warbyparker.com
Warby Parker Inc. is a direct-to-consumer eyewear and vision care company structured as a public benefit corporation. It designs and sells prescription glasses starting at $95, sunglasses and contact lenses, and provides eye exams and vision tests both online and in its 364 retail stores across the U.S. and Canada.
Its omnichannel model combines e-commerce with a growing store base, with 50 new stores planned for 2026. It also includes an expanding services business:
- eye exams and in-network insurance access
- the Warby Parker Care rollout
- higher-value lens offerings such as progressives
The company is moving into smart glasses. It plans to open pre-orders for its first Intelligent Eyewear collection on November 12, 2026, and cites partnerships with Google and Samsung.
Through its Buy a Pair, Give a Pair program, Warby Parker distributes a pair of glasses for every pair sold and has distributed more than 25 million pairs with nonprofit partners. It has a multi-class share structure in which its co-founders and co-CEOs, Neil Blumenthal and Dave Gilboa, hold significant influence. The company sunset its Home Try-On program at the end of 2025. Updated
Earnings came in at less than half what analysts expected as retail compensation and technology spending ate the margin, with revenue rising 10.4% but still missing expectations. The spending has a deadline attached: pre-orders for the first Intelligent Eyewear collection, built with Google and Samsung, open November 12.
Warby Parker Inc. is a direct-to-consumer eyewear and vision care company structured as a public benefit corporation. It designs and sells prescription glasses starting at $95, sunglasses and contact lenses, and provides eye exams and vision tests both online and in its 364 retail stores across the U.S. and Canada.
The Wall Street consensus 12-month price target for WRBY is $31.00.